RO7790121
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7790121, covering 2026-04-03 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis [Phase 1]